bd 1047 has been researched along with galantamine in 1 studies
Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (galantamine) | Trials (galantamine) | Recent Studies (post-2010) (galantamine) |
---|---|---|---|---|---|
118 | 0 | 54 | 1,874 | 209 | 703 |
Protein | Taxonomy | bd 1047 (IC50) | galantamine (IC50) |
---|---|---|---|
Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.652 | |
Chain A, Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.36 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.0401 | |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.488 | |
Cholinesterase | Homo sapiens (human) | 5.4792 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.59 | |
Acetylcholinesterase | Mus musculus (house mouse) | 2.29 | |
Acetylcholinesterase | Homo sapiens (human) | 1.8484 | |
Acetylcholinesterase | Bos taurus (cattle) | 4.53 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 8.3973 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.59 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.59 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.8006 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.2 | |
Cholinesterase | Equus caballus (horse) | 7.2215 | |
Carboxylic ester hydrolase | Equus caballus (horse) | 8.4178 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ieni, J; Maurice, T; Meunier, J | 1 |
1 other study(ies) available for bd 1047 and galantamine
Article | Year |
---|---|
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
Topics: Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Behavior, Animal; Donepezil; Dose-Response Relationship, Drug; Ethylenediamines; Fluorescent Dyes; Galantamine; Indans; Injections, Intraventricular; Lipid Peroxidation; Male; Maze Learning; Mice; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phenols; Phenylcarbamates; Piperidines; Receptors, sigma; Rivastigmine; Sulfoxides; Xylenes | 2006 |